Schedule-at-a-Glance

View Full Schedule

NOTE: All meeting session times are in U.S. Eastern Daylight Time.

Friday, September 30

6:00 pm - 8:00 pmNBF Party with a Purpose

Saturday, October 1

7:00 am - 7:00 pmRegistration
7:00 am - 8:30 amNBF R&D Summit
7:15 am - 8:15 amBiotherapies Welcome Breakfast
8:30 am - 9:30 amConcurrent continuing education sessions
  • ST01- Novel Data Science Techniques in Blood Banking/Transfusion Medicine: State-of-the-Art and Future Directions
  • ST02- Do More with Less: How to Apply the 80/20 Rule to Quality Assurance
  • ST03- Blood Safety: Epidemiological Surveillance and Risk Assessment for Emerging Pathogens
  • ST04- How an Anti-c Antibody Prompted a 10-Year Journey of Life Saving Work Between a Transfusion Service and a Blood Center Reference Laboratory
  • ST05- Heart Transplantation and High-Risk Cardiac Surgery - Transfusion Support and Perioperative Therapies
  • ST06- New Frontiers for Unmanipulated Cord Blood as Well as Its Derivatives
10:00 am - 11:00 amConcurrent continuing education sessions
  • ST07- Inspection Findings and Compliance Updates from FDA’s Office of Regulatory Affairs Inspectorate – Where Does Your Firm Rank Regarding the Most Cited Deficiencies on FDA-483s?
  • ST08- Making Better Decisions to Reduce Errors in Transfusion Medicine
  • ST09- What if the Next Pandemic Is Transmissible by Transfusion? Strategies for Protecting the Blood Supply
  • ST10- LVDS - Is It Worth It?
  • ST11- Emily Cooley Memorial Award and Lectureship
  • ST12- Managing the Apheresis Center: How Do We Produce Enough Products for the Ever-Increasing Demand?
11:30 am - 12:30 pmConcurrent continuing education sessions
  • ST13- New Plasma and Platelet Transfusion Guidance for Critically Ill Children from the Transfusion Anemia Expert Initiative – Control/Avoidance of Bleeding (TAXI-CAB)
  • ST14- Impact of COVID-19 Pandemic on Blood Collection and Utilization in the United States: Preliminary Results from the 2021 National Blood Collection and Utilization Survey
  • ST15- Desafíos Serológicos y Moleculares Dentro Del Sistema Del Grupo Sanguíneo Rh / Serologic and Molecular Challenges Within the Rh Blood Group System
  • ST16- Clear the Way for X-Ray: Discussing Benefits of Removing and Replacing Cesium Irradiators with X-Ray
  • ST17- Cutting Edge Concepts in Pathogenesis, Diagnosis, and Treatment of Warm Autoimmune Hemolytic Anemia
  • ST18- Oral Abstract Session- Components
12:45 pm - 2:00 pmNew Member & First Time Attendee Lunch
12:45 pm - 2:00 pmIndustry Workshops
2:15 pm - 3:15 pmConcurrent continuing education sessions
  • ST19- Low-Yield Platelets: An Effective Solution to Our Platelet Shortage?
  • ST20- Coverage and Reimbursement Policy for Transfusion Medicine and Cellular Therapies: What US Hospitals Need to Know in 2022
  • ST21- A New Piece of Equipment... Now What?
  • ST22- How Climate Change May Change Infectious Diseases Risks in Blood Donors and What Can Blood Operators Do to Prepare for Shifting Threat Profiles
  • ST23- Oral Abstract Session- RBC Immunology- Mouse Models
  • ST24- Solve It! Scenarios in Cellular Therapy
3:30 pm - 5:00 pmGeneral Session
5:15 pm - 7:00 pmExhibit Hall & Opening Night Reception

Sunday, October 2

6:30 am - 6:00 pmRegistration
7:00 amNBF Run for Research
7:00 am - 8:15 amIndustry Workshops
7:00 am - 8:30 amNBF R&D Summit
8:30 am - 9:30 amConcurrent continuing education sessions
  • SN01- More Challenging Antibody Investigations in the Immunohematology Reference Laboratory
  • SN02- Ask the FDA and CMS/CLIA
  • SN04- Innovations in Blood Storage to Prevent Red Blood Cell Damage
  • SN05- New Prospects for Treatment and Prophylaxis of Fetal and Neonatal Alloimmune Thrombocytopenia
  • SN06- AABB/THOR Joint Workshop (continuous until 12 pm)
9:30 am - 4:30 pmExhibit Hall Open (Posters and Science & Innovation Theaters)
10:00 am - 11:00 amConcurrent continuing education sessions
  • SN07- Ethical Considerations in Blood Supply Management During Critical Blood Shortages
  • SN08- Sally Frank Memorial Award and Lectureship
  • SN09- Management of Patients in the Hematopoietic Stem Cell and Solid Organ Transplant Setting Who Decline Blood Transfusion
  • SN10- Lowering the Dose of Platelets – Is the Timing Right? The North American Perspective
  • SN11- Hemolysis After High-Dose Intravenous Immunoglobulin: An Under-Appreciated Sequelae
11:30 am - 1:00 pmBiotherapies Sizzling Topics Lunch
11:30 am - 1:00 pmIRL Lunch
1:30 pm - 2:30 pmConcurrent continuing education sessions
  • SN12- Armed Services Blood Program: Pioneering Collaborations to Forge Ahead Within the Military Health System Transformation
  • SN13- The BLOODSAFE Program – Building the Future of Access to Safe Blood in Sub-Saharan Africa Using Implementation Research
  • SN14- Oral Abstract Session- Genetic Testing and Product Quality
  • SN15- Jehovah’s Witnesses – The Medical and Ethical Challenges
  • SN16- Managing Challenging MNC/HPC Cell Collections – Quality & Quantity
  • SN17- DEIA in Focus 1: Advancing Equity and Inclusivity for Sexual and Gender Diverse Donors
3:00 pm - 4:00 pmConcurrent continuing education sessions
  • SN18- Wizardry School of Antigens and Antibodies
  • SN19- Hemphill-Jordan Leadership Award
  • SN20- Moving Beyond the Label – How the MPHO Unique Identifier Improves Traceability and Enhances Biovigilance
  • SN21- Changes in the Last Decade in Patient Blood Management Practices
  • SN22- Global Regulatory Pathways for Biotherapies – Spotlight on New Regulations in Gulf Cooperation Council and Latin American Countries and the European Union
  • SN23- DEIA in Focus 2: Engaging Diverse Ethnocultural Communities Through Community-Based Research
4:30 pm - 6:00 pmPlenary Oral Abstract Session
6:30 pm – 7:45 pmIndustry Workshops

Monday, October 3

6:30 am - 6:00 pmRegistration
7:00 am - 8:15 amIndustry Workshops
7:00 am - 8:30 amNBF R&D Summit
8:30 am - 9:30 amConcurrent continuing education sessions
  • MN01- Is It Time for the Death Knell of the Current US Apheresis Platelet Dose of 3.0 x 1011?
  • MN02- Oral Abstract Session- Infectious Disease
  • MN03- Blood Shortage Triage Team: Engaging Hospital Leaders
  • MN04- Blood and Stem Cell Centers as Contract Manufacturers in Support of Biotherapy Development: Synergy and Challenges
  • MN05- How Does the FDA Use Real World Data?
  • MN06- SBB/BB Exam Review (continuous until 5:30)
9:30 am - 4:30 pmExhibit Hall Open (Posters and Science & Innovation Theaters)
10:00 am - 11:00 amConcurrent continuing education sessions
  • MN07- Transfusion Strategies for Intracerebral Hemorrhage: Evidence, Guidelines, and Novel Approaches
  • MN08- Leveraging Your Data Through Replication and Warehousing to Meet Your Blood Bank and Transfusion Service Needs
  • MN09- Oral Abstract Session- Platelets and Novel Therapeutics
  • MN10- Landsteiner-Alter Award and Lectureship
  • MN11- Cryopreservation of Cellular Therapy Products for Allogeneic Stem Cell Transplantation During COVID-19 Pandemic and Beyond
11:30 am - 1:00 pmNBF Research Symposium
1:30 pm - 2:30 pmConcurrent continuing education sessions
  • MN13- Ask the Standards
  • MN15- Leadership and Personal Development
  • MN16- Tibor Greenwalt Memorial Award and Lectureship
  • MN17- Who Is Transfusing Blood in Your Neighborhood? Trends in Out-of-Hospital Transfusions
3:00 pm - 4:00 pmConcurrent continuing education sessions
  • MN19- COVID-19 – Impact on Blood Availability and Transfusion Practices in Low- and Middle-Income Countries
  • MN20- How Donors Contribute to Public Health Research – Blood Centers Chart a New Course
  • MN21- Leadership and Personal Development
  • MN22- Oral Abstract Session- PBM, Hemovigilance, Education
  • MN23- Effects of Transfusion on Bone Marrow Health and Transplant Outcomes in Sickle Cell Disease
4:30 pm - 5:30 pmConcurrent continuing education sessions
  • MN25- Keeping up with the Donor History Task Force – Implementation of DHQ Version 3.0
  • MN26- Elevating Blood Collectors’ Role in Promoting Donor Health, Particularly in Underserved Communities
  • MN27- Leadership and Personal Development
  • MN28- Under-Recognized Transfusion Reactions
  • MN29- Cellular Therapy Service Quality System Considerations from a Standards Development and Application Perspective
  • MN30- Ultimate Test Your Blood Bank Knowledge 2022
5:45 pm – 6:45 pmResearch and Progress Sessions (Topics TBD)
6:30 pm – 7:45 pmIndustry Workshops
7:30 pm - 9:00 pmPresident's Reception

Tuesday, October 4

6:30 am - 10:00 amRegistration
7:00 am - 8:15 amIndustry Workshops
8:30 am - 9:45 amCritical Conversations (two sessions/topics TBD)
10:00 am - 11:15 amCritical Conversations (two sessions/topics TBD)
11:15 am2022 Annual Meeting Adjournment

Note: Times subject to change